DECLARE TIMI 58 (Follow up)
Dapagliflozin Effect on Cardiovascular Events.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes.
- Middel
- dapagliflozin
- Populatie
- preventie (diabetes)
- Fase
- III
- Jaar aanvang
- 2013
- Meer informatie
- ClinicalTrials.gov